Emerging Drug Therapies for Inherited Retinal Dystrophies

Files in This Item:
Access to this item has been restricted by the copyright holder until:2020-12-29
File SizeFormat 
XX.Sundaramurthi.docx94.57 kBMicrosoft Word    Request a copy
Title: Emerging Drug Therapies for Inherited Retinal Dystrophies
Authors: Sundaramurthi, Husvinee
Permanent link: http://hdl.handle.net/10197/11581
Date: 29-Dec-2019
Online since: 2020-09-22T14:18:45Z
Abstract: Worldwide, 1 in 2000 people suffer from inherited retinal dystrophies (IRD). Individuals with IRD typically present with progressive vision loss that ultimately results in blindness. Unfortunately, effective treatment options are not widely available due to the genetic and clinical heterogeneity of these diseases. There are multiple gene, cell, and drug-based therapies in various phases of clinical trials for IRD. This mini-review documents current progress made in drug-based clinical trials for treating IRD.
Type of material: Conference Publication
Publisher: Springer
Series/Report no.: Advances in Experimental Medicine and Biology; 1185
Copyright (published version): 2019 Springer
Keywords: Inherited retinal dystrophiesDrug-based therapiesClinical trials
DOI: 10.1007/978-3-030-27378-1_43
Language: en
Status of Item: Peer reviewed
Is part of: Bowes Rickman C., Grimm C., Anderson R., Ash J., LaVail M., Hollyfield J. (eds.). Retinal Degenerative Diseases
ISBN: 978-3-030-27377-4
Appears in Collections:Conway Institute Research Collection
SBI Research Collection
Biomolecular and Biomedical Science Research Collection
Medicine Research Collection
Veterinary Medicine Research Collection

Show full item record

Page view(s)

Last Week
Last month
checked on Oct 25, 2020


checked on Oct 25, 2020

Google ScholarTM



This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.